Pan, K., Baig, Y., Willis, J., Dasari, A., Bent, A. H., Higbie, V., Huey, R. W., Kee, B. K., Lee, M. S., Parseghian, C., Morelli, M. P., Shen, J. P. Y., Kopetz, S., Morris, V. K. (2025). Phase I/II trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAF V600E metastatic colorectal cancer following progression on prior BRAF+EGFR targeted therapies.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.182